Quanterix Announces Leadership Transition Plan

BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (ā€œQuanterixā€ or the ā€œCompanyā€) (NASDAQ: QTRX), a global leader in precision biomarker science, today announced that Everett Cunningham has stepped down as President and Chief Executive Officer and as a member of the Company’s Board of Directors (the ā€œBoardā€), effective immediately, to accept an opportunity in another area of the healthcare sector. The Board has appointed Jim Gute, Quanterix’s Chief Commercial Officer, to serve in the addi
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks